Regulatory agencies employ a variety of strategies to ensure the safety of nanotechnology applications. These include risk assessment and management protocols, stringent testing requirements, and post-market surveillance. Agencies like the FDA have specific guidelines for the evaluation of nanomaterials in medical products, while the EPA focuses on the environmental impact of nanomaterials. Collaborative efforts, such as the OECD Working Party on Manufactured Nanomaterials, also play a crucial role in developing international standards and best practices.
